期刊文献+

复合中心对称设计法制备喜树碱非离子表面活性剂囊泡 被引量:2

Camptothecin Niosomes Prepared by Central Composite Design
下载PDF
导出
摘要 采用复合中心对称设计法优化喜树碱非离子表面活性剂囊泡的处方和工艺 ,得到的优化条件为 :药物与非离子表面活性剂用量比 1∶ 10 ,非离子表面活性剂与胆固醇用量比 1∶ 0 .6 ,水合搅拌速度 80 0 r/ min,水合温度 5 5°C,5 0 m g药物的分散介质体积 5 0 m The formulation and process of preparing camptothecin niosomes were optimized by central composite design. The results showed that the optimization conditions were as follows: the ratios of drug to non-ionic surfactant and non-ionic surfactant to cholesterol were 1∶10 and 1∶0.6, respectively; hydration at 55 °C and stirring rate of 800 r/min; dispersion solution volume per 50 mg drug was 50 ml.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2003年第10期504-506,共3页 Chinese Journal of Pharmaceuticals
  • 相关文献

参考文献6

  • 1栾立标,朱家壁,余卫平,卫开斌.喜树碱囊泡的研制[J].药学学报,2002,37(1):59-62. 被引量:25
  • 2Luftensteiner CP, Viernstein H. Statistical experimental design based studies on placebo and mitoxantrone-loaded albumin microspheres[J]. Int J Pharm, 1998, 17(1):87-99.
  • 3McLeod AD, Lam FC, Gupta PK, et al. Optimized synthesis of polyglutaraldehyde nanoparticles using central composite design[J].J Pharm Sci, 1988, 77.
  • 4Chandraprakash KS, Udupa N, Umadevi P, et al.Formulation and evaluation of methotrexate niosomes[J]. Indian J Pharm Sci, 1992, 54(5) : 197-200.
  • 5Baillie AJ, Coombs GH, Doaln TF, et al. Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate[J].J Pharm Pharmacol, 1986, 38(7) :502-505.
  • 6Baillie A J, Florence AT, Hume LR, et al. The preparation and properties of niosomes-non-ionic surfactant vesicles[J]. J Pharm Pharmacol, 1985, 37(12) :863-868.

二级参考文献6

  • 1[1]Handjani-Vila RM, Ribier A, Rondot B, et al. Dispersions of lamellar phases of non-ionic lipids in cosmetic products. Int J Cosmet Sci [J], 1979,1(5):303-314.
  • 2[2]Baillie AJ, Florence AT, Hume LR, et al. The preparation and properties of niosomes-non-ionic surfactant vesicles. J Pharm Pharmacol [J], 1985,37(12):863-868.
  • 3[3]Namdeo A, Jain NK. Niosomes as drug carriers. Indian J Pharm Sci [J], 1996,58(2):41-46.
  • 4[4]Andersson M, Hammarstrom L, Edwards K. Effect of bilayer phase transitions on vesicle structure and its influence on the kinetics of viologen reduction. J Phys Chem [J], 1995,99(39):14531-14538.
  • 5[5]Slichenmyer WJ, Rowinsky EK, Donehower RC, et al. The current status of camptothecin analogues as antitumor agents. J Natl Cancer Inst [J], 1993,85(4):271-291.
  • 6[6]Arunothayanun P, Turton JA. Uchegbu IF, et al. Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical/tubular niosome. J Pharm Sci [J], 1999,88(1):34-38.

共引文献24

同被引文献41

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部